Capital Fund Management S.A. Pfizer Inc Put Options Transaction History

Capital Fund Management S.A.

$34.4 Billion
Q1 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $15.9 Million - $18.2 Million	-613,600 Reduced 13.1%	4,072,000 $113 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $53.4 Million - $69.3 Million	2,042,300 Added 77.26%	4,685,600 $135 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $25.4 Million - $29.7 Million	792,300 Added 42.8%	2,643,300 $87.7 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $15.9 Million - $18.4 Million	441,400 Added 31.31%	1,851,000 $67.9 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $26.9 Million - $35 Million	683,400 Added 94.11%	1,409,600 $57.5 Million

Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $13.5 Million - $17.7 Million	-324,400 Reduced 30.88%	726,200 $37.2 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $5.39 Million - $6.58 Million	123,100 Added 13.27%	1,050,600 $46 Billion
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $20.9 Million - $24.7 Million	-448,100 Reduced 32.57%	927,500 $48.6 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $15.2 Million - $18.8 Million	331,800 Added 31.79%	1,375,600 $71.2 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $27.3 Million - $40.5 Million	660,800 Added 172.53%	1,043,800 $61.6 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $15 Million - $19.3 Million	383,000 New	383,000 $16.5 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $4.62 Million - $5.21 Million	-138,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $485,315 - $617,120	-14,500 Reduced 9.51%	138,000 $5.08 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $3.84 Million - $4.51 Million	-121,000 Reduced 44.24%	152,500 $5.31 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $19.1 Million - $23.2 Million	-634,900 Reduced 69.89%	273,500 $8.48 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $13.7 Million - $19.6 Million	-508,600 Reduced 35.89%	908,400 $28.1 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $375,288 - $425,904	-11,400 Reduced 0.8%	1,417,000 $55.5 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $30.7 Million - $39.9 Million	946,300 Added 196.29%	1,428,400 $51.3 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $6.22 Million - $6.98 Million	-168,100 Reduced 25.85%	482,100 $20.9 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $33.2 Million - $36.5 Million	-885,000 Reduced 57.65%	650,200 $27.6 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $12.6 Million - $14.4 Million	327,700 Added 27.14%	1,535,200 $67 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $29.8 Million - $36.2 Million	865,500 Added 253.07%	1,207,500 $53.2 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $3.75 Million - $3.99 Million	-113,600 Reduced 24.93%	342,000 $12.4 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $27.3 Million - $31.6 Million	-854,700 Reduced 65.23%	455,600 $16.2 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $21.7 Million - $23.1 Million	653,900 Added 99.62%	1,310,300 $47.5 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $20.3 Million - $22.4 Million	656,400	656,400 $23.4 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

Vanguard Group Inc Valley Forge, PA

507M
Shares

$14.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

431M
Shares

$12.1 Billion
0.28% of portfolio
State Street Corp Boston, MA

291M
Shares

$8.13 Billion
0.37% of portfolio
Wellington Management Group LLP Boston, MA

178M
Shares

$4.97 Billion
0.89% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

122M
Shares

$3.42 Billion
0.79% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account